January 2024 in “Journal of cellular immunology” Hair follicle stem cells are important for maintaining healthy skin and interact with many signals.
January 2024 in “Editora In Vivo eBooks” Early diagnosis and management are crucial for feline inflammatory bowel disease.
January 2024 in “Editora In Vivo eBooks” Dogs can transmit a parasite to humans, especially affecting those with weak immune systems, so early diagnosis and treatment are crucial.
January 2024 in “Editora In Vivo eBooks” Illegal cattle slaughter in Brazil poses health risks and violates laws.
January 2024 in “Editora In Vivo eBooks” H5N1 avian flu poses risks to birds and humans, requiring strict biosecurity measures.
January 2024 in “Editora In Vivo eBooks” Laser therapy helps relieve pain and improve life quality in small animals with osteoarthritis.
January 2024 in “Editora In Vivo eBooks” Veterinarians are essential for ensuring animal welfare and safe meat products in Brazil.
January 2024 in “Editora In Vivo eBooks” Cryptosporidiosis in dogs can spread to humans, so prevention is crucial.
January 2024 in “Editora In Vivo eBooks” Giardiasis in dogs poses a public health risk, requiring better diagnosis, treatment, and sanitation.
October 2023 in “Frontiers in endocrinology” Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.
Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.
October 2021 in “Research Square (Research Square)” Melatonin affects certain genes and pathways involved in cashmere goat hair growth.
June 2021 in “Research Square (Research Square)” Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.
March 2021 in “bioRxiv (Cold Spring Harbor Laboratory)” Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.
September 2020 in “Annals of the National Academy of Medical Sciences. India” COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.
December 2019 in “University of Malaya Students Repository” Mimosine from Leucaena leucocephala can enhance biodiesel stability.
January 2018 in “Springer eBooks” Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.
June 2016 in “CRC Press eBooks” Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.
Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.
September 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” Blocking CCR5 can prevent and improve hair loss in alopecia areata.
3 citations
,
November 2024 in “Viruses” Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.
8 citations
,
January 2025 in “Cell Transplantation” MSC-derived EVs show promise for therapy, but production and understanding need improvement.
46 citations
,
January 2020 in “Theranostics” Injecting a special gel with human protein particles can help hair grow.
January 2019 in “Research & Reviews: Journal of Pharmaceutics and Nanotechnology” Nanotechnology can effectively deliver antimicrobial peptides for treating infections.
May 2010 in “OPAL (Open@LaTrobe) (La Trobe University)” Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.
23 citations
,
January 2009 in “Veterinary Dermatology” The hepatitis B vaccine did not cause hair loss in the tested mice.
51 citations
,
August 2021 in “Turkish Journal of Medical Sciences” As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.
45 citations
,
July 2025 in “Journal of Medicinal Chemistry” Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.
February 2020 in “Oncology Times” Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.